Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN
|
March 2, 2013
Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials
Yizhi Chen, Arrigo Schieppati, Guangyan Cai, et al.
The Cochrane Database of Systematic Reviews
|
October 17, 2014
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome
Yizhi Chen, Arrigo Schieppati, Xiangmei Chen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 1, 2017
BRAF Signaling Pathway Inhibition, Podocyte Injury, and Nephrotic Syndrome
Luca Perico, Mario Mandalà, Arrigo Schieppati, et al.
Pediatric Nephrology (Berlin, Germany)
|
September 1, 2014
Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy
Rosanna Coppo, Licia Peruzzi, Alessandro Amore, et al.
Blood Transfusion = Trasfusione Del Sangue
|
June 13, 2014
The social burden and quality of life of patients with haemophilia in Italy
Yllka Kodra, Marianna Cavazza, Arrigo Schieppati, et al.
Lancet (London, England)
|
March 11, 2015
Rare diseases and effective treatments: are we delivering?
Lucio Luzzatto, Carla E M Hollak, Timothy M Cox, et al.
Lancet (London, England)
|
July 25, 2018
Outrageous prices of orphan drugs: a call for collaboration
Lucio Luzzatto, Hanna I Hyry, Arrigo Schieppati, et al.
Lancet (London, England)
|
June 4, 2013
Kidney failure: aims for the next 10 years and barriers to success
Giuseppe Remuzzi, Ariela Benigni, Fredric O Finkelstein, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 4, 2016
Social/economic costs and health-related quality of life in patients with scleroderma in Europe
Julio López-Bastida, Renata Linertová, Juan Oliva-Moreno, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 25, 2016
Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe
Aris Angelis, Panos Kanavos, Julio López-Bastida, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Clinical Journal of the American Society of Nephrology : CJASN
|
March 2, 2013
Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials
Yizhi Chen, Arrigo Schieppati, Guangyan Cai, et al.
The Cochrane Database of Systematic Reviews
|
October 17, 2014
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome
Yizhi Chen, Arrigo Schieppati, Xiangmei Chen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 1, 2017
BRAF Signaling Pathway Inhibition, Podocyte Injury, and Nephrotic Syndrome
Luca Perico, Mario Mandalà, Arrigo Schieppati, et al.
Pediatric Nephrology (Berlin, Germany)
|
September 1, 2014
Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy
Rosanna Coppo, Licia Peruzzi, Alessandro Amore, et al.
Blood Transfusion = Trasfusione Del Sangue
|
June 13, 2014
The social burden and quality of life of patients with haemophilia in Italy
Yllka Kodra, Marianna Cavazza, Arrigo Schieppati, et al.
Lancet (London, England)
|
March 11, 2015
Rare diseases and effective treatments: are we delivering?
Lucio Luzzatto, Carla E M Hollak, Timothy M Cox, et al.
Lancet (London, England)
|
July 25, 2018
Outrageous prices of orphan drugs: a call for collaboration
Lucio Luzzatto, Hanna I Hyry, Arrigo Schieppati, et al.
Lancet (London, England)
|
June 4, 2013
Kidney failure: aims for the next 10 years and barriers to success
Giuseppe Remuzzi, Ariela Benigni, Fredric O Finkelstein, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 4, 2016
Social/economic costs and health-related quality of life in patients with scleroderma in Europe
Julio López-Bastida, Renata Linertová, Juan Oliva-Moreno, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 25, 2016
Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe
Aris Angelis, Panos Kanavos, Julio López-Bastida, et al.
Page
of 6